Flu Vaccine Shortage Shows Hazards Of Market Concentration – Sen. Leahy
Executive Summary
The Bush Administration should have "learned their lesson" from last year's influenza vaccine shortages, Sen. Patrick Leahy (D-Vt.) says
You may also be interested in...
BIO “Follow-On” Biologics Risk-Based Proposal Would Require Clinical Tests
The Biotechnology Industry Organization's risk-based approach to a regulatory pathway for "follow-on" biologics would include a clinical testing requirement
BIO “Follow-On” Biologics Risk-Based Proposal Would Require Clinical Tests
The Biotechnology Industry Organization's risk-based approach to a regulatory pathway for "follow-on" biologics would include a clinical testing requirement
FDA Approves Use Of Fluarix Under An IND; GSK To Submit BLA In First Half ’05
GlaxoSmithKline plans to establish a presence in the U.S. influenza vaccine market with a BLA submission for Fluarix in the first half of 2005